XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholder's Equity
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Stockholder's Equity

7. Stockholder’s Equity

On August 3, 2020, in connection with the closing of the Company’s IPO, the Company filed its amended and restated certificate of incorporation, which authorizes the Company to issue up to 10,000,000 shares of preferred stock, $0.0001 par value per share. There were no shares of preferred stock issued or outstanding at September 30, 2022 and December 31, 2021.

At September 30, 2022 and December 31, 2021, the Company’s amended and restated certificate of incorporation authorized the Company to issue 150,000,000 shares of common stock at a par value of $0.0001 per share.

On July 26, 2022, the Company entered into the Securities Purchase Agreement with certain investors for aggregate net proceeds of $126.4 million after deducting issuance costs of $0.2 million. Pursuant to the terms of the Securities Purchase Agreement, the Company agreed to issue and sell to the investors in a registered direct offering an aggregate of 27,458,095 shares of the Company's common stock, par value $0.0001 per share (the "Shares") at a purchase price of $4.61 per Share (the "Offering"). The Offering was

made without an underwriter or a placement agent, and therefore, there were no underwriting discounts or commissions in connection with the offering.

The Company has reserved shares of common stock for issuance as follows:

 

 

 

September 30,
2022

 

 

December 31,
2021

 

Options to purchase common stock

 

 

8,499,509

 

 

 

6,155,055

 

Unvested restricted stock

 

 

2,746,971

 

 

 

2,866,909

 

Stock available for grant under the 2020 Stock Option and Grant Plan

 

 

3,550,703

 

 

 

3,812,396

 

Stock available for issuance under the 2020 Employee Stock Purchase Plan

 

 

537,997

 

 

 

611,354

 

Total

 

 

15,335,180

 

 

 

13,445,714